Jeremy Grantham reported an equity portfolio valued at approximately $39.10 billion in the latest quarter, reflecting GMO's long-standing focus on high-quality businesses with durable competitive advantages and strong long-term earnings power. The portfolio remains broadly diversified across technology, healthcare, financials, and industrials, while maintaining meaningful concentration in a select group of large-cap holdings. The latest
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.